LGP
Habi Pharma Pty Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79255400 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | L50 |
| Employee Name | GULIANO, ROBERT N |
Timeline
| 2018-10-04 | Application Filed |
| 2019-10-25 | Abandon |
| 2019-11-13 | Location: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED |
| 2019-11-13 | Status: Dead/Abandoned |
| 2019-11-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  HABI PHARMA PTY LTD |
| Address | C/- Coote & Associates, C7 1-3 The Esplanade; MOUNT PLEASANT WA XP |
| Legal Entity Type | |
| Legal Entity State | XP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Materials for use in applying pharmaceutical preparations (terms too vague in the opinion of the International Bureau - Rule 13 (2) (b) of the Common Regulations); pharmaceutical compositions; pharmaceutical creams; pharmaceutical drugs; pharmaceutical medicaments in unit dosage form; pharmaceutical preparations; pharmaceutical preparations for alleviating disorders of the brain; pharmaceutical preparations for application to the skin; pharmaceutical preparations for human use; pharmaceutical preparations for oral use; pharmaceutical preparations for personal use; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical preparations for topical use; pharmaceutical preparations for use in the treatment of muscle tension; pharmaceutical preparations in the form of emulsions; pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical products for infants; pharmaceutical products for the central nervous system; pharmaceutical products for the treatment of gastrointestinal disorders; pharmaceutical products for use by humans; pharmaceutical substances; pharmaceutical tablets; pharmaceutical tonic preparations; plant extracts for pharmaceutical purposes; plant extracts for pharmaceutical use; preparations of plants for pharmaceutical use |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-03-28 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-04-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2019-04-02 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-04-02 | 4 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-04-03 | 5 RFCR E:E-Mail |
| APPLICATION FILING RECEIPT MAILED | 2019-04-06 | 6 MAFR O:Outgoing Correspondence |
| REFUSAL PROCESSED BY MPU | 2019-04-24 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-04-24 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2019-05-10 | 9 RFNT P: |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2019-11-13 | 10 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2019-11-13 | 11 MAB2 O:Outgoing Correspondence |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2020-03-06 | 12 ADCH M: |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2020-09-02 | 13 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-09-06 | 14 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2020-09-26 | 15 OPNX P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-11-13 | 16 FICR P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-11-13 | 17 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-12-12 | 18 FINT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-01-01 | 19 NREP P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 